The U.S. Judicial Panel on Multidistrict Litigation announced consolidation and centralization of all nationwide Xarelto lawsuits filed in federal courts before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana. Over 50 Federal Xarelto Lawsuits Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to…
Today, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments to consolidate all federal Xarelto lawsuits before one judge, in one centralized U.S. District Court. It is widely anticipated that the U.S. JPML will establish centralized proceedings for coordinated discovery and a series of bellwether trials. Patients who…
Recently Shirley Boynton from California filed a product liability lawsuit against Bayer Healthcare and Johnson & Johnson’s Janssen subsidiary claiming that she almost died from uncontrollable hemorrhaging after using the new anticoagulant medication Xarelto. The complaint was filed in the U.S. District Court for the Eastern District of New York.…
Xarelto is a popular blood-thinning drug or anticoagulant made by Bayer Health Care and Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). Xarelto, Pradaxa and Eliquis, are the new generation of anticoagulants that have been advertised as requiring less testing and monitoring than coumadin for stroke prevention. Common problem with…
Germany based Boehringer Ingelheim, the manufacturer of the anticoagulant medication Pradaxa has agreed to pay $650 million to settle Pradaxa injury lawsuits. There are 4,000 lawsuits on file by folks who allege that the company failed to warn about the risk of severe and deadly bleeding problems with the anticoagulant…
U.S. District Judge Herndon, who is presiding over all federal Pradaxa lawsuits has established the pretrial schedule for the first bellwether trial. On September 8, 2014, the first trial will involve the wrongful death lawsuit brought by Suzanne Mackiewicz, on behalf of her mother, Malachy Higgins. The Higgins case is…